Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a (Q36982528)
scientific article published on June 1, 1990
Language:
(P31) (Q13442814)
(P304) 1620-1627
(P407) (Q1860)
(P433) 6
(P478) 58
(P577) Friday, June 1, 1990
(P921) (Q12090)
(Q101929)
(Q7193)
(Q22111431)
(P953) http://iai.asm.org/cgi/content/abstract/58/6/1620
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1692807/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1692807/pdf/?tool=EBI
https://europepmc.org/articles/PMC258689
https://europepmc.org/articles/PMC258689?pdf=render
https://journals.asm.org/doi/pdf/10.1128/iai.58.6.1620-1627.1990
(P1433) (Q6029193)
(P1476) "Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a" (language: en)
(P2093) C. O. Tacket
B. Forrest
R. Morona
S. R. Attridge
J. LaBrooy
B. D. Tall
M. Reymann
D. Rowley
M. M. Levine
(P2860) (Q33910000)
(Q36340620)
(Q40346098)
(Q39568025)
(Q39513114)
(Q37082660)
(Q37098602)
(Q28485732)
(Q37042161)
(Q40825801)
(Q33628356)
(Q34257127)
(Q37607544)
(Q40145625)
(Q37345416)
(Q36911515)
(Q36911199)
(Q36911214)
(Q36911188)
(Q36785879)
(Q30531885)
(Q34488645)
(Q40166583)
(Q37276116)
(Q40791588)
(Q39766925)
(Q37005140)
(Q36992602)
(Q37009163)
(Q40160672)
(Q39649727)
(Q39649722)
(Q40807068)
(Q40797037)
(Q36213903)
(Q37219389)
(Q38662784)
(Q40776571)
(Q37026444)
(Q40806387)
(Q34389674)
(Q40897058)
(Q34097649)
(Q36338304)
(Q39774242)
(Q37589261)
(Q39459483)
(Q42263884)
(Q42262286)
(Q50240557)
(Q50204703)
(Q50206204)
(Q50201133)
(Q47910752)
(Q50197203)
(Q50196400)
(Q50197025)
(Q54378370)
(Q50198684)
(Q46726270)
(Q50201269)
(Q48245954)
(Q41593317)
(Q57926262)
(Q70404018)
(Q72715141)
(Q69877492)
(Q69007734)
(Q59075403)
(Q70313647)
(Q70831304)
other details
description scientific article published on June 1, 1990

External Links